Wolverine Asset Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,069
Closed -$7.93K 1767
2025
Q2
$7.93K Buy
4,069
+1,467
+56% +$3.06K ﹤0.01% 1401
2025
Q1
$4.58K Buy
2,602
+1,586
+156% +$3.61K ﹤0.01% 1379
2024
Q4
$2.7K Buy
+1,016
New +$2.62K ﹤0.01% 1463
2024
Q1
Sell
-3,904
Closed -$5.89K 1835
2023
Q4
$5.89K Sell
3,904
-2,500
-39% -$3.22K ﹤0.01% 1449
2023
Q3
$8.58K Hold
6,404
﹤0.01% 1495
2023
Q2
$11.5K Hold
6,404
﹤0.01% 1373
2023
Q1
$10.6K Buy
6,404
+2,178
+52% +$4.41K ﹤0.01% 1440
2022
Q4
$8.11K Hold
4,226
﹤0.01% 1662
2022
Q3
$9K Buy
4,226
+440
+12% +$1.26K ﹤0.01% 2011
2022
Q2
$12K Buy
3,786
+460
+14% +$2.01K ﹤0.01% 1938
2022
Q1
$17K Buy
3,326
+516
+18% +$2.9K ﹤0.01% 1796
2021
Q4
$23K Sell
2,810
-438
-13% -$4.03K ﹤0.01% 1686
2021
Q3
$32K Sell
3,248
-7,175
-69% -$65K ﹤0.01% 1523
2021
Q2
$97K Buy
10,423
+9,670
+1,284% +$110K ﹤0.01% 1488
2021
Q1
$7K Sell
753
-14,524
-95% -$162K ﹤0.01% 1898
2020
Q4
$178K Sell
15,277
-32,236
-68% -$335K ﹤0.01% 1100
2020
Q3
$532K Buy
+47,513
New +$513K ﹤0.01% 717

Other funds holding NUVB

Wolverine Asset Management's NUVB Position: Q3 2025 in Review

Wolverine Asset Management sold out of Nuvation Bio (NUVB) in Q3 2025, closing a stake of 4,069 shares — an estimated $7.93K sold.

Wolverine Asset Management first reported a position in NUVB in Q3 2020 and held it in 17 quarters. The position peaked at $532K in Q3 2020. 203 funds tracked by Wall St. Rank hold NUVB as of Q3 2025.

  • Wolverine Asset Management reported no remaining Nuvation Bio position as of Q3 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 4,069 Nuvation Bio shares in Q3 2025, an estimated $7.93K.
  • Wolverine Asset Management first reported a position in Nuvation Bio in Q3 2020 and held it in 17 quarters.
  • Wolverine Asset Management's Nuvation Bio position peaked at $532K in Q3 2020.
  • 203 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.